Technology

Technology: Redefining Wound Healing with BioHeal Hydrogel XG-100

At BIOHEAL THERAPEUTICS, we are advancing wound care solutions with our innovative BioHeal Hydrogel, developed using our proprietary BioHeal Matrix Technology (BMT). This advanced solubilized amnion membrane technology is an alternative to traditional amnion-based products, supporting advanced wound care practices worldwide.

Who Can Benefit?

BioHeal Hydrogel address the challenges in hard-to-heal injuries such as chronic wounds and burns. Although not available in the United States, its designed for patients and healthcare systems globally. Consider these key statistics:

• Diabetes Impact: Approximately 37.3 million Americans have diabetes, with many at risk for diabetic foot ulcers.
• Chronic Wounds: Over 5.2 million adults suffer from chronic wounds annually.
• Burns: More than 1 million people in the U.S. experience severe burns and abrasions each year.

These conditions contribute to significant healthcare costs, emphasizing the need for advanced wound care solutions. 

The Science Behind BioHeal Matrix Technology (BMT)

BioHeal Matrix Technology (BMT) uses solubilized amnion membranes to create a hydrogel that:

• Retains moisture: Establishes a moisture-rich barrier for effective wound repair.
• Enhances healing: Integrates hyaluronic acid to promote angiogenesis and cell proliferation.
• Ensures biocompatibility: Maintains non-immunogenic properties to reduce immune rejection risks.

Key Features 

• Ease of Use: Simple preparation and application without sutures or staples.
• Moisture Retention: Sustains an optimal healing environment by preventing wound drying.
• Non-Stick Application: Absorbs into the wound bed without adhering, minimizing dressing disruption.
• Storage-Friendly: Stable at room temperature for easy transportation and storage.

Research and Development

Collaborative studies: Backed by preclinical studies and research with the Wake Forest Institute for Regenerative Medicine (WFIRM). Efficacy insights: Laboratory and preclinical findings indicate potential in promoting wound closure and integration with surrounding tissues.

Please note: Specific claims efficacy claims are based on laboratory and preclinical findings, with ongoing research to further explore  applications.

Global Reach and Commitment

• Patent Portfolio: 12 global patents (issued or pending) covering the U.S., Canada, Europe, Australia, Japan, and South Korea.
• Initial Funding: Supported by the U.S. Department of Defense for treating treating severe burns and wounds in military applications.
• Ongoing Collaboration Partnership with WFIRM to ensure that we remain at the forefront of amnion and hyaluronic acid technology.

Transforming Wound Care Worldwide

BIOHEAL THERAPEUTICS is dedicated to delivering innovative wound care solutions that improves outcomes for patients and clinicians globally. BioHeal Hydrogel stands as a testament to our to advancing regenerative medicine and addressing wound care challenges.

For more information, contact us today to learn how BioHeal Hydrogel can drive wound care innovation.